What is tab Citicoline used for?

In the pharmaceutical industry, Citicoline (CDP-Choline) tablets—typically manufactured in 500 mg and 1000 mg strengths—are classified as nootropic and neuroprotective agents. As a pharmacist, I view Citicoline as a “brain-building block” because it provides the essential components for repairing neuronal membranes and increasing neurotransmitter levels.

Primary Clinical Uses

  • Acute Ischemic Stroke: Administered to minimize the extent of brain damage and improve motor and cognitive recovery following a stroke.

  • Traumatic Brain Injury (TBI): Used to reduce the severity and duration of post-traumatic coma and accelerate functional recovery.

  • Cognitive Decline & Dementia: Prescribed for age-related memory loss, Alzheimer’s disease, and vascular dementia to enhance memory and attention.

  • Glaucoma & Optic Neuropathy: Increasingly used in ophthalmology to protect retinal ganglion cells and slow the progression of vision loss.

  • Parkinson’s Disease: Often used as an adjunctive therapy to Levodopa to improve motor function and reduce the required dose of dopamine-replacement therapy.

Mechanism of Action

Citicoline is a complex molecule that breaks down into choline and cytidine upon ingestion. These components then cross the Blood-Brain Barrier and work through three main pathways:

Membrane Phospholipid Synthesis: It serves as a precursor for phosphatidylcholine, the primary structural component of neuronal membranes. This helps repair damaged neurons.

Neurotransmitter Support: It increases the synthesis of acetylcholine, the primary neurotransmitter involved in memory and learning.

ATP Preservation: It enhances mitochondrial function and prevents the accumulation of free radicals, protecting brain cells from oxidative stress.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Citicoline is a high-value neuro-specialty product:

  • API Purity & Stability: Citicoline is highly hygroscopic (absorbs moisture). As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging and climate-controlled production areas to ensure the tablets do not degrade or become sticky during their 24-month shelf life.

    Dose Versatility: We manufacture both 500 mg and 1000 mg tablets, often with a “break-line” for easy titration. For advanced recovery, we also develop Citicoline + Piracetam combinations.

  • Niche Market Reach: This is a high-demand item for neurology clinics and specialized B2B distributors in the CIS, Southeast Asia, and the Middle East.

  • Regulatory Readiness: Our Mumbai hub provides comprehensive CTD/eCTD Dossiers and stability data for Zone IVb, facilitating smooth registration for international pharmaceutical trade.

What is Ciprofloxacin 500mg and Tinidazole 600 mg used for?

In the pharmaceutical industry, the combination of Ciprofloxacin (500 mg) and Tinidazole (600 mg) is a powerful broad-spectrum antimicrobial therapy. As a pharmacist, I view this as a “dual-action” formulation designed to cover nearly all likely pathogens in mixed infections, combining a potent fluoroquinolone with an advanced antiprotozoal/anaerobic agent.

Primary Clinical Uses

  • Gastrointestinal Infections: Highly effective for infectious diarrhea, bacillary dysentery, and amoebic dysentery where both bacteria and protozoa (like Giardia or E. histolytica) may be present.

  • Gynecological Infections: Used to treat Pelvic Inflammatory Disease (PID), bacterial vaginosis, and mixed vaginal infections.

  • Intra-abdominal Infections: Management of complex infections within the abdominal cavity, often following surgery or trauma.

  • Dental Infections: Used for severe dental abscesses or periodontitis where anaerobic bacteria are prevalent.

  • Prophylaxis: Occasionally used as a surgical prophylaxis to prevent post-operative infections in contaminated or “dirty” surgeries.

Mechanism of Action: The Synergistic Approach

This combination attacks pathogens on two distinct fronts:

Ciprofloxacin (500 mg): A fluoroquinolone that inhibits DNA Gyrase and Topoisomerase IV. It prevents bacterial DNA from unwinding and replicating, leading to rapid cell death. It primarily targets aerobic Gram-negative and some Gram-positive bacteria.

Tinidazole (600 mg): A second-generation nitroimidazole. Once it enters a cell, it is reduced to form highly reactive free radicals that bond with the DNA of anaerobic bacteria and protozoa, causing strand breakage and cell death. It has a longer half-life and better side-effect profile than Metronidazole.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, this FDC (Fixed-Dose Combination) is a high-demand export item:

  • Bilayer Tablet Technology: Given the different physical properties and dosages (500mg/600mg), we often use bilayer compression or specialized granulation to ensure stability and consistent release profiles for both APIs.

  • Taste Masking: Both APIs are inherently bitter. As a WHO-GMP manufacturer, we utilize a robust film-coating process to ensure the tablet is palatable and easy for patients to swallow.

  • Stability for Export: Tinidazole is sensitive to light and moisture. We utilize Alu-Alu blister packaging to guarantee a 36-month shelf life, especially for export to Zone IVb regions (Africa, SE Asia, and the Middle East).

  • Global Registration: Our Mumbai facility provides comprehensive CTD/eCTD Dossiers and stability data to support our international B2B partners in rapid market entry.

What is Ciprofloxacin 100mg used for?

In the pharmaceutical industry, Ciprofloxacin 100 mg is a second-generation fluoroquinolone antibiotic. As a pharmacist, I view this specific low-strength dosage as a targeted therapeutic tool, primarily utilized in pediatric care or for very specific, uncomplicated adult infections where higher doses (250 mg or 500 mg) are not clinically necessary.

Primary Clinical Uses

  • Uncomplicated Urinary Tract Infections (UTIs): Frequently used for short-course treatment of acute, uncomplicated cystitis in women.

  • Pediatric Applications: Used to treat complicated UTIs and pyelonephritis in children (ages 1-17), where the dosage is strictly weight-based.

  • Post-Exposure Inhalation Anthrax: Part of the prophylactic regimen for children and adults following exposure to Bacillus anthracis.

  • Cystic Fibrosis: Management of pulmonary exacerbations caused by Pseudomonas aeruginosa in pediatric patients.

  • Gonorrhea: Though resistance has limited its use, it was historically used as a single 100 mg dose for uncomplicated urethral and endocervical infections.

Mechanism of Action

Ciprofloxacin is a rapidly bactericidal agent. It works by inhibiting two essential bacterial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV.

By targeting these enzymes, Ciprofloxacin prevents the bacteria from “unzipping” and repairing their DNA during replication. This leads to irreversible DNA damage and rapid bacterial cell death. Its broad-spectrum activity is particularly effective against Gram-negative pathogens like E. coli and Pseudomonas.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ciprofloxacin 100 mg requires precise quality controls:

  • API Purity: As a WHO-GMP manufacturer, we ensure the Ciprofloxacin Hydrochloride API meets strict BP/USP/IP standards, specifically monitoring for the “Ethylenediamine” impurity.

  • Taste Masking: Ciprofloxacin is extremely bitter. We utilize advanced film-coating technology to ensure the 100 mg tablet is palatable, especially given its frequent use in adolescent and pediatric populations.

  • Stability for Global Trade: Ciprofloxacin is light-sensitive. We utilize Alu-Alu or opaque PVC/PVDC blister packaging to maintain its 36-month shelf life during export to hot and humid Zone IVb regions (Africa and Southeast Asia).

  • B2B & Tender Supply: This strength is a staple for pediatric hospital tenders and international NGOs. Our Mumbai facility provides full CTD/eCTD Dossiers to support rapid registration for our B2B partners.

What is Ciprofloxacin 250mg used for?

In the pharmaceutical industry, Ciprofloxacin 250 mg is a broad-spectrum second-generation fluoroquinolone antibiotic. As a pharmacist, I classify it as a “workhorse” antibiotic due to its exceptional tissue penetration and high efficacy against Gram-negative pathogens, particularly Enterobacteriaceae.

Primary Clinical Uses

  • Urinary Tract Infections (UTIs): Often used for both uncomplicated and complicated UTIs, including cystitis and pyelonephritis.

  • Respiratory Tract Infections: Effective against acute sinusitis and certain types of pneumonia, especially those involving Gram-negative bacteria.

  • Gastrointestinal Infections: A frontline treatment for “traveler’s diarrhea” (caused by E. coli), typhoid fever (Salmonella Typhi), and shigellosis.

  • Skin and Bone Infections: Used for osteomyelitis and skin structure infections caused by susceptible organisms.

  • Anthrax Prophylaxis: Specifically indicated for post-exposure prophylaxis of inhalational anthrax.

Mechanism of Action

Ciprofloxacin acts by inhibiting the bacterial enzymes DNA gyrase (Topoisomerase II) and Topoisomerase IV. These enzymes are essential for the replication, transcription, and repair of bacterial DNA.

By interfering with these processes, Ciprofloxacin causes double-stranded breaks in the bacterial DNA, leading to rapid cell death. It is a bactericidal antibiotic, meaning it kills the bacteria rather than just inhibiting their growth.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Ciprofloxacin is a staple of any anti-infective portfolio:

  • Solubility and Bioavailability: Ciprofloxacin HCl is highly soluble. As a WHO-GMP manufacturer, we focus on optimized disintegration times to ensure rapid absorption, typically reaching peak plasma concentrations within 1–2 hours.

  • Taste Masking: The API is intensely bitter. We utilize advanced film-coating technology to ensure the 250 mg tablets are palatable and easy to swallow, which is critical for patient compliance.

  • Packaging for Stability: Ciprofloxacin can be sensitive to light. We use PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb climates (Africa, SE Asia).

  • B2B and Tender Volume: Because it is on the WHO Model List of Essential Medicines, it is a high-volume item for international health tenders. Our Mumbai-based facility provides full CTD/eCTD Dossier support for registration across global markets.

 

Is Cinnarizine a sleeping pill?

To give you a direct, technical answer: No, Cinnarizine is not classified as a sleeping pill. It is officially categorized as an antihistamine and a calcium channel antagonist.

However, as a pharmacist, I can tell you that the confusion is common because drowsiness is its most frequent side effect. In the pharmaceutical trade, we often refer to it as a “sedating antihistamine.”

Primary Clinical Uses

Cinnarizine is primarily manufactured and exported for:

  • Motion Sickness: Prevention and treatment of nausea and vomiting during travel.

  • Vestibular Disorders: Managing balance issues like Vertigo, Tinnitus (ringing in the ears), and Ménière’s disease.

  • Cerebral & Peripheral Circulatory Disorders: Improving blood flow in conditions like Raynaud’s disease or memory/concentration issues in the elderly.

Mechanism of Action: Why it makes you sleepy

Cinnarizine works through a dual pathway:

L-type Calcium Channel Blockade: It inhibits the influx of calcium ions into arterial smooth muscle cells, causing vasodilation and improving microcirculation in the inner ear.

H1-Receptor Antagonism: It blocks histamine receptors. Unlike “non-drowsy” antihistamines (like Cetirizine), Cinnarizine easily crosses the Blood-Brain Barrier. Once in the brain, it suppresses the vestibular system (which controls balance) but also interferes with the wakefulness-promoting effects of histamine in the central nervous system, leading to sedation.

The Manufacturer’s Perspective: Export & Formulation

If you are looking to include this in your trading portfolio or promote it on your digital platforms, here are the technical highlights:

  • Standard Strengths: Typically manufactured as 25 mg (for motion sickness) and 75 mg (for vestibular/circulatory issues).

  • Stability: Cinnarizine is highly stable but sensitive to light. We utilize PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life for export to hot Zone IVb climates.

  • Market Position: It is a high-demand item in B2B marketplaces for “Travel Health” and “Geriatric Care” segments.

  • Regulatory Status: It is widely available in Europe, India, and Southeast Asia, though it is not FDA-approved in the USA, which is a key detail for your exporting strategy.

What is Cimetidine 400mg used for?

In the pharmaceutical industry, Cimetidine 400 mg is the pioneer H2-receptor antagonist (H2RA) used to suppress gastric acid secretion. While newer proton pump inhibitors (PPIs) have gained popularity, Cimetidine remains a vital, cost-effective therapeutic option for managing acid-peptic disorders, especially in international markets where affordability is a priority.

Primary Clinical Uses

  • Duodenal and Gastric Ulcers: Indicated for the short-term treatment of active ulcers and as maintenance therapy to prevent recurrence.

  • Gastroesophageal Reflux Disease (GERD): Relieves symptoms like heartburn and acid regurgitation caused by the backflow of stomach acid into the esophagus.

  • Zollinger-Ellison Syndrome: Manages pathological hypersecretory conditions where the stomach produces excessive amounts of acid.

  • Prophylaxis of GI Bleeding: Used in critical care settings to prevent stress-induced ulcers and upper gastrointestinal bleeding.

  • Off-label Dermatological Use: Occasionally used in high doses for the treatment of viral warts (verrucae) due to its immunomodulatory properties.

    Mechanism of Action

Cimetidine works by competitively inhibiting histamine at the H2-receptors located on the basolateral membrane of the gastric parietal cells.

By blocking these receptors, it inhibits both the basal (fasting) and stimulated (food-induced) secretion of gastric acid. This results in a significant reduction in the volume of gastric juice and its hydrogen ion concentration, allowing the mucosal lining to heal.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Cimetidine 400 mg is a high-volume, “essential medicine” staple:

  • Drug-Drug Interactions (CYP450): As a pharmacist, you know Cimetidine is a potent inhibitor of several cytochrome P450 enzymes (e.g., 1A2, 2C9, 2D6). In our professional labeling and dossiers, we emphasize these interactions to ensure patient safety when co-administered with drugs like Warfarin or Theophylline.

  • Stability for Global Markets: Cimetidine is a stable molecule, but as a WHO-GMP manufacturer, we utilize PVC/PVDC or Alu-Alu blister packaging to ensure its 36-month shelf life remains intact during export to Zone IVb climates (Africa, SE Asia, and Latin America).

  • B2B & Public Health Tenders: Because Cimetidine is often more affordable than modern PPIs, it remains a high-demand item for government health tenders and low-cost B2B distribution networks.

  • Regulatory Readiness: Our Mumbai-based facility provides comprehensive CTD/eCTD Dossiers and stability data (BP/USP/IP) to facilitate rapid registration for our international partners.

What is Cilostazol 50 mg used for?

In the pharmaceutical industry, Cilostazol 50 mg is a specific phosphodiesterase III (PDE3) inhibitor with potent antiplatelet and vasodilatory properties. As a pharmacist, I view Cilostazol as a unique therapeutic agent because, unlike standard antiplatelets like Aspirin, it actively improves blood flow by dilating the arteries while simultaneously preventing clot formation.

Primary Clinical Uses

  • Intermittent Claudication: The primary indication for Cilostazol is the reduction of symptoms of intermittent claudication (leg pain, cramping, or tiredness while walking) in patients with Peripheral Arterial Disease (PAD). It increases the distance patients can walk without pain.

  • Secondary Stroke Prevention: In some regions, it is used as an alternative or adjunct for the prevention of ischemic stroke, particularly in patients who cannot tolerate other antiplatelet therapies.

  • Percutaneous Coronary Intervention (PCI): Occasionally used off-label to prevent restenosis after stent placement.

  • Buerger’s Disease (Thromboangiitis Obliterans): Used to improve circulation in the small and medium-sized arteries of the hands and feet.

Mechanism of Action

Cilostazol works through a dual-action biochemical pathway:

Inhibition of PDE3: By inhibiting the phosphodiesterase III enzyme, Cilostazol increases the levels of cyclic adenosine monophosphate (cAMP) within platelets and blood vessel walls.

Antiplatelet Effect: Higher cAMP levels in platelets prevent them from aggregating (clumping), which reduces the risk of thrombus formation.

Vasodilation: Increased cAMP in the vascular smooth muscle cells leads to relaxation of the arteries (vasodilation), which directly increases blood flow to the limbs.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Cilostazol 50 mg is a specialized cardiovascular product:

  • Bioavailability Challenges: Cilostazol is practically insoluble in water. As a WHO-GMP manufacturer, we utilize micronization technology to reduce particle size, ensuring consistent dissolution and optimal absorption.

  • Dose Titration: We manufacture both 50 mg and 100 mg strengths. The 50 mg tablet is essential for patients who require a lower dose due to side effects like headaches or for those taking co-medications (like CYP3A4 inhibitors) that increase Cilostazol levels.

  • Stability for Export: We utilize Alu-Alu blister packaging to protect the tablets from moisture and light, ensuring a 24-month shelf life for export to Zone IVb regions (Africa, SE Asia, and the Middle East).

  • Regulatory Support: Our Mumbai-based facility provides comprehensive CTD/eCTD Dossiers and comparative dissolution data against the innovator (Pletal) to support international registration and B2B trade.

What is Trypsin Chymotrypsin Tablet 100000 used for?

In the pharmaceutical industry, Trypsin-Chymotrypsin tablets (standardized at 100,000 Armour Units) are a potent proteolytic enzyme combination. As a pharmacist, I view this formulation as a highly effective “biological response modifier” used to accelerate the resolution of inflammatory edema and promote tissue repair following trauma or surgery.

Primary Clinical Uses

  • Post-Operative Inflammation: Extensively used after surgical procedures (orthopedic, gynecological, or general surgery) to reduce swelling, hematoma (bruising), and pain at the incision site.

  • Traumatic Injuries: Indicated for the management of accidental injuries, such as sprains, strains, fractures, and sports-related soft tissue trauma.

  • Chronic Respiratory Conditions: Used as an adjunctive therapy in conditions like bronchitis and sinusitis to thin out thick mucus secretions (mucolytic effect), making them easier to expectorate.

  • Pelvic Inflammatory Disease (PID): Often prescribed in gynecology to resolve inflammation and improve the penetration of antibiotics into the affected tissues.

  • Tooth Extractions: Frequently used in dentistry to minimize post-extraction swelling and pain.

Mechanism of Action

Trypsin and Chymotrypsin are enzymes that act as anti-inflammatory catalysts. Unlike NSAIDs (which inhibit COX enzymes), these proteolytic enzymes work through the following pathways:

Fibrinolysis: They break down fibrin deposits that form around inflamed areas. These fibrin walls often “wall off” the infection, trapping fluid and preventing antibiotics from reaching the site.

Restoring Microcirculation: By clearing fibrin and cellular debris, these enzymes restore the flow of blood and lymph in the micro-vasculature. This reduces edema (swelling) and allows the body’s natural defense mechanisms to clear the inflammation.

TNF-$\alpha$ Modulation: They help regulate pro-inflammatory cytokines, preventing an excessive or prolonged inflammatory response.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Trypsin-Chymotrypsin is a technically sensitive biological product:

  • Enteric Coating (Crucial): These enzymes are proteins that would be instantly destroyed by stomach acid. As a WHO-GMP manufacturer, we utilize a high-quality enteric coating that ensures the tablet remains intact in the stomach and only dissolves in the $pH$-neutral environment of the small intestine.

  • Potency & Standardization: We measure efficacy in Armour Units (or AU). Ensuring that each tablet provides exactly 100,000 units requires precise API handling and environmental controls to prevent enzymatic degradation during the manufacturing process.

  • Stability for Export: Enzymes are heat-sensitive. We prioritize Alu-Alu blister packaging to protect the tablets from moisture and temperature fluctuations during transit to Zone IVb regions.

  • B2B & Surgical Supply: This is a high-demand item for surgical hospitals and orthopedic clinics. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required for international registration and hospital tenders.

What is Cholecalciferol 60000 IU granules used for?

In the pharmaceutical industry, Cholecalciferol (Vitamin D3) 60,000 IU granules represent a high-potency “mega-dose” formulation. As a pharmacist, I characterize this product as a therapeutic loading dose rather than a daily supplement. It is specifically designed to rapidly correct clinical vitamin D deficiency and replenish depleted hepatic and adipose stores.

Primary Clinical Uses

  • Treatment of Vitamin D Deficiency: Specifically for patients with serum 25-hydroxyvitamin D [25(OH)D] levels significantly below 20 ng/mL.

  • Osteoporosis Management: Used as an intensive adjunct to primary osteoporosis therapies (like Bisphosphonates) to ensure adequate calcium absorption and bone mineralization.

  • Osteomalacia & Rickets: Essential for reversing the softening of bones in adults (osteomalacia) and correcting skeletal deformities in children (rickets).

  • Malabsorption Syndromes: Frequently prescribed for patients with conditions like Celiac disease, Crohn’s disease, or post-bariatric surgery, where standard daily doses are insufficient due to poor intestinal absorption.

  • Hypoparathyroidism: Used to maintain calcium homeostasis when parathyroid hormone function is compromised.

Mechanism of Action

Cholecalciferol is a fat-soluble vitamin that acts more like a pro-hormone. Once ingested:

  1. Hydroboxylation: It undergoes two hydroxylation steps—first in the liver to form 25(OH)D (Calcifediol) and then in the kidneys to form 1,25$(OH)_2$D (Calcitriol), the biologically active form.

  2. Target Action: Calcitriol binds to Vitamin D Receptors (VDR) in the intestines to stimulate the synthesis of calbindin, a protein that actively transports calcium across the intestinal mucosa into the bloodstream.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, 60,000 IU granules are a high-value niche product:

  • Granulation Technology: As a WHO-GMP manufacturer, we utilize fluid-bed processing to create free-flowing granules. The Vitamin D3 is often “beadletted” or micro-encapsulated to protect it from oxidation and light, which are the primary causes of degradation.

  • Sachet Packaging: Granules are typically packed in 1g or 2g triple-laminated sachets (Polyester/Alu/Poly) to provide a complete barrier against moisture and oxygen, ensuring a stable 24-month shelf life even in Zone IVb climates.

  • Dosing Schedule: Unlike daily tablets, these granules are usually administered once weekly or once monthly, which significantly improves patient compliance for chronic bone-health management.

  • Global Export Profile: Operating from Mumbai, we provide the CTD/eCTD Dossiers and stability data required for international registration. This high-strength formulation is a staple for B2B distributors in regions with limited sunlight or high rates of nutritional deficiency.

 

What is Chlorpromazine 25mg used for?

In the pharmaceutical industry, Chlorpromazine Hydrochloride 25 mg is the prototypical first-generation (typical) antipsychotic of the phenothiazine class. As a pharmacist, I characterize Chlorpromazine as a “low-potency” antipsychotic that is highly versatile due to its multi-receptor blocking profile, making it useful far beyond psychiatry.

Primary Clinical Uses

  • Psychotic Disorders: Management of schizophrenia and the manic phase of bipolar disorder, particularly for controlling agitation and aggressive behavior.

  • Severe Nausea and Vomiting: Used as a potent antiemetic, especially for intractable nausea caused by advanced illness or certain medications.

  • Intractable Hiccups: It is one of the few medications specifically indicated for the treatment of hiccups that have persisted for days or weeks.

  • Acute Intermittent Porphyria: Used as part of the clinical management of this rare metabolic disorder.

  • Pre-operative Sedation: Occasionally used to reduce anxiety and induce sedation before surgery.

Mechanism of Action

Chlorpromazine is a “dirty drug” in pharmacological terms—meaning it acts on a wide variety of receptors, which explains its diverse clinical effects:

Dopamine Antagonism: It blocks  receptors in the mesolimbic and medullary chemoreceptor trigger zone (CTZ). By inhibiting dopamine overactivity, it reduces “positive” symptoms of psychosis and provides antiemetic effects.

H1-Receptor Blockade: Its action on histamine receptors leads to significant sedation, useful for acute agitation.

Alpha-Adrenergic Blockade: This can lead to cardiovascular effects like orthostatic hypotension.

Muscarinic Blockade: Its anticholinergic effects can cause dry mouth and blurred vision.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Chlorpromazine 25 mg is a specialized CNS (Central Nervous System) product:

  • Photosensitivity Management: Chlorpromazine API is highly sensitive to light. As a WHO-GMP manufacturer, we utilize amber-colored glass bottles or opaque blister packaging to ensure chemical stability.

  • Dose Uniformity: Because 25 mg is a relatively low dose for this molecule, we utilize validated wet granulation and blending processes to ensure absolute content uniformity across every batch.

  • Global Export Stability: It remains a staple for psychiatric hospitals and government tenders in the CIS, Africa, and Southeast Asia. We provide the CTD/eCTD Dossiers and stability data required for international registration.

  • Regulatory Standards: We ensure all batches comply with BP/USP/IP monographs, specifically monitoring for degradation products like Chlorpromazine Sulfoxide.

Add to cart